Alkem Laboratories Ltd
NSE:ALKEM

Watchlist Manager
Alkem Laboratories Ltd Logo
Alkem Laboratories Ltd
NSE:ALKEM
Watchlist
Price: 4 792 INR -0.44%
Market Cap: 572.9B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+7%
Revenue
Forecast
+29%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

ALKEM Price Targets Summary
Alkem Laboratories Ltd

Wall Street analysts forecast ALKEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALKEM is 5 304.6 INR with a low forecast of 4 070.3 INR and a high forecast of 7 174.65 INR.

ALKEM Lowest Forecast
Wall Street Target
4 070.3 INR
15% Downside
ALKEM Average Forecast
Wall Street Target
5 304.6 INR
11% Upside
ALKEM Highest Forecast
Wall Street Target
7 174.65 INR
50% Upside
Lowest
Price Target
4 070.3 INR
15% Downside
Average
Price Target
5 304.6 INR
11% Upside
Highest
Price Target
7 174.65 INR
50% Upside
Alkem Laboratories Ltd Competitors:
Price Targets
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
4% Downside
C
2M7C
China Medical System Holdings Ltd
1% Upside
600195
China Animal Husbandry Industry Co Ltd
11% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
11% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
4% Downside
C
2M7C
China Medical System Holdings Ltd
1% Upside
600195
China Animal Husbandry Industry Co Ltd
11% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
11% Upside
SUPRIYA
Supriya Lifescience Ltd
6% Downside

Revenue
Forecast

Revenue Estimate
Alkem Laboratories Ltd

For the last 13 years the compound annual growth rate for Alkem Laboratories Ltd's revenue is 15%. The projected CAGR for the next 3 years is 11%.

15%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Alkem Laboratories Ltd

For the last 13 years the compound annual growth rate for Alkem Laboratories Ltd's operating income is 15%. The projected CAGR for the next 3 years is 17%.

15%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Alkem Laboratories Ltd

For the last 13 years the compound annual growth rate for Alkem Laboratories Ltd's net income is 14%. The projected CAGR for the next 3 years is 9%.

14%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
ALKEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALKEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALKEM stock valuation using valuation multiples.
Wall Street Estimates
ALKEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALKEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALKEM's stock price target?
Price Target
5 304.6 INR

According to Wall Street analysts, the average 1-year price target for ALKEM is 5 304.6 INR with a low forecast of 4 070.3 INR and a high forecast of 7 174.65 INR.

What is Alkem Laboratories Ltd's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Alkem Laboratories Ltd's revenue is 15%. The projected CAGR for the next 3 years is 11%.

What is Alkem Laboratories Ltd's Operating Income forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Alkem Laboratories Ltd's operating income is 15%. The projected CAGR for the next 3 years is 17%.

What is Alkem Laboratories Ltd's Net Income forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Alkem Laboratories Ltd's net income is 14%. The projected CAGR for the next 3 years is 9%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.